Cahill represented BofA Merrill Lynch, J.P. Morgan, Rabo Securities, Barclays, and Wells Fargo Securities as joint book-running managers and the co-managers in connection with the public offering of $650,000,000 principal amount of 4.625% Senior Notes due 2023 by Constellation Brands, Inc.
Tags: Cahill Gordon & Reindel LLP | New YorkCahill – EP Energy Completes $350 Million Notes Offering
Cahill represented Citigroup, Deutsche Bank Securities, J.P. Morgan, Nomura, and Wells Fargo Securities as joint book-running managers and the co-managers in connection with the Rule 144A/Reg S offering of $350,000,000 7.75% Senior Notes due 2022 by EP Energy LLC. Proceeds from the offering were used to refinance existing indebtedness and for general corporate purposes.
Tags: Cahill Gordon & Reindel LLP | New YorkDavis Polk Advises PepsiCo, Inc. on Its $2.5 Billion Notes Offering
Davis Polk advised PepsiCo, Inc. on its registered offering of $900 million aggregate principal amount of 0.7% senior notes due 2015, $1 billion aggregate principal amount of 1.25% senior notes due 2017 and $600 million aggregate principal amount of 3.6% senior notes due 2042. Citigroup Global Markets Inc., Morgan Stanley & Co. LLC and RBS Securities Inc. acted as joint book-running managers for the offering.
Tags: Davis Polk & Wardwell | New YorkSimpson Thacher Represents The Carlyle Group in Acquisition of TCW
Simpson Thacher is representing affiliates of The Carlyle Group in connection with their acquisition of The TCW Group, Inc. (“TCW”) from Société Générale. Founded in 1971, TCW is a Los Angeles-based diversified asset management firm offering U.S. equities and fixed income, international and alternative strategies, with approximately $130 billion under management. The transaction is subject to customary closing conditions and is expected to close in the first quarter of 2013. Financial terms were not disclosed.
Tags: Simpson Thacher & Bartlett LLP | New YorkShearman & Sterling Advises Sun Pharmaceutical on Merger with Taro Pharmaceutical
Shearman & Sterling is advising Sun Pharmaceutical Industries Ltd. (Sun Pharma) on its merger agreement with Taro Pharmaceutical Industries Ltd. (Taro). Upon completion of the merger, Taro will become a privately held company, will be wholly owned by affiliates of Sun Pharma, and its ordinary shares will no longer be traded on the New York Stock Exchange. The closing of the merger is subject to certain terms and conditions customary for transactions of this type.
Tags: Shearman & Sterling LLP | New YorkDavis Polk – Westar Energy, Inc. SEC-Registered Dribble-Out Offering and Forward Component
Davis Polk is advising Westar Energy, Inc. in connection with an SEC-registered dribble-out offering and related forward transactions as part of its existing $500 million continuous equity financing program. BNY Mellon Capital Markets, LLC, acted as the sales agent.
Tags: Davis Polk & Wardwell | New YorkDavis Polk – StanCorp Financial Group, Inc. $250 Million Notes Offering
Davis Polk advised Barclays Capital Inc., Goldman, Sachs & Co. and J.P. Morgan Securities LLC as joint book-running managers in connection with an offering by StanCorp Financial Group, Inc. of $250 million aggregate principal amount of 5% senior notes due 2022.
Tags: Davis Polk & Wardwell | New YorkDavis Polk Advises Ingram Micro on $300 Million Notes Offering
Davis Polk advised Ingram Micro Inc. on its SEC-registered debt offering of $300 million aggregate principal amount of senior notes due 2022. The offering was made through an underwriting syndicate led by Morgan Stanley & Co. LLC and RBS Securities Inc.
Tags: Davis Polk & Wardwell | New YorkChadbourne Represents Southern Cross Latin America Private Equity Fund IV, L.P. in Connection with Signing of Investment Agreement with Estrella International Energy Services Ltd.
Orrick Advises VanceInfo in US$875 Million All-Stock Merger with hiSoft Technology
Orrick, Herrington & Sutcliffe LLP is representing VanceInfo Technologies Inc. in its tax-free, all-stock merger of equals with hiSoft Technology International Limited, valued at US$875 million.
Tags: Orrick, Herrington & Sutcliffe, LLP | New York